AU606989B2 - New yeast strains providing for an enhanced rate of the fermentation of sugars, a process to obtain such yeasts and the use of these yeasts - Google Patents

New yeast strains providing for an enhanced rate of the fermentation of sugars, a process to obtain such yeasts and the use of these yeasts Download PDF

Info

Publication number
AU606989B2
AU606989B2 AU21868/88A AU2186888A AU606989B2 AU 606989 B2 AU606989 B2 AU 606989B2 AU 21868/88 A AU21868/88 A AU 21868/88A AU 2186888 A AU2186888 A AU 2186888A AU 606989 B2 AU606989 B2 AU 606989B2
Authority
AU
Australia
Prior art keywords
yeast
gene
baker
maltose
pgb
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU21868/88A
Other versions
AU2186888A (en
Inventor
Robert Franciscus Beudeker
Johannes Abraham De Hollander
Klaas Anne Osinga
Johannes Bertus Van Der Plaat
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Koninklijke DSM NV
Original Assignee
Gist Brocades NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gist Brocades NV filed Critical Gist Brocades NV
Publication of AU2186888A publication Critical patent/AU2186888A/en
Application granted granted Critical
Publication of AU606989B2 publication Critical patent/AU606989B2/en
Assigned to DSM N.V. reassignment DSM N.V. Alteration of Name(s) in Register under S187 Assignors: GIST-BROCADES N.V.
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/24Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405Glucanases
    • C12N9/2408Glucanases acting on alpha -1,4-glucosidic bonds
    • AHUMAN NECESSITIES
    • A21BAKING; EDIBLE DOUGHS
    • A21DTREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
    • A21D8/00Methods for preparing or baking dough
    • A21D8/02Methods for preparing dough; Treating dough prior to baking
    • A21D8/04Methods for preparing dough; Treating dough prior to baking treating dough with microorganisms or enzymes
    • A21D8/047Methods for preparing dough; Treating dough prior to baking treating dough with microorganisms or enzymes with yeasts
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14Fungi; Culture media therefor
    • C12N1/16Yeasts; Culture media therefor
    • C12N1/18Baker's yeast; Brewer's yeast
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52Genes encoding for enzymes or proenzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90Stable introduction of foreign DNA into chromosome
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/02Preparation of oxygen-containing organic compounds containing a hydroxy group
    • C12P7/04Preparation of oxygen-containing organic compounds containing a hydroxy group acyclic
    • C12P7/06Ethanol, i.e. non-beverage
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02EREDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
    • Y02E50/00Technologies for the production of fuel of non-fossil origin
    • Y02E50/10Biofuels, e.g. bio-diesel

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Botany (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Bakery Products And Manufacturing Methods Therefor (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Distillation Of Fermentation Liquor, Processing Of Alcohols, Vinegar And Beer (AREA)
  • Mechanical Treatment Of Semiconductor (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

New yeast strains providing for an enhanced rate of the fermentation of sugars, and a process to obtain such yeasts and the use of these yeasts. Yeasts capable of improved fermentation of sugars, a process to obtain these yeasts and the use of these yeasts are provided. The yeasts show higher rates of metabolism resulting in for example higher carbon dioxide and ethanol production in media containing sugars, such as maltose, as main carbon and energy source. The fermentation rate of sugars is improved by the introduction into a yeast of one or more DNA constructs comprising at least one gene encoding a protein promoting the uptake and/or initial metabolic conversion of a transported sugar substrate.

Description

AUSTRALIA
Patents Act (ORIGINA Class Int. Class Application Number: Lodged: Complete Specification Lodged: Accepted: Published: Priority Related Art: This document contain's the amendments Made under Section 49 and is correct for printing.
Ii APPLICANT'S REFERENCE: AUJS-2468 Name(s) of Applicant(s): Gist-Brocades WV :Address(es) of Applicant(s): Wateringseweg 1, 2611 XT, Delft, THE NETHERILNDS.
Address for Service is: PHILLIPS OR~tE FITZPATRICK Patent and Trade Mark Attorneys 367 Collins Street Melbourne 3000 AUSTRALIA Complete Specification for the invention entitled: NEW YEA~ST STRAINS PiIVDl-K3 FOR AN ENHANCED) RATE OF TEE F~EU'?TATICIN OF SUX~kPS, A PEIRCES To OBTAISIXH YEASTS AND THE USE OF THESE YEASTS Our Ref 103814 POF Code: 1219/1219 The following statement is a full description of this invention, including the best method of performing it known to applicant(s): 6003q/1 -1I- Gist-Brocades N.V.
2468-S
A-
New yeast strains providing for an enhanced rate of the fermentation of sugars, a process to obtain such yeasts and the use of these yeasts.
The invention relates to new yeasts capable of improving the fermentation of sugars, to a process to construct such yeasts and to the use of these improved yeasts.
It is well known that yeast strains belonging for example to the genus Saccharomyces are capable of fermenting sugars to approximately equimolar amounts of C02 and ethanol under anaerobic conditions. The leavening activity of yeast in dough is a result of this fermentation. The commercial proauct baker's yeast exists in several formulations comprising compressed yeast or fresh yeast and dried yeast. Dried yeast is available as active dry yeast and as instant dry yeast with moisture contents of about 6-8% and respectively.
One of the early steps in the metabolism of sugars by the action of yeast is the transport of Lhe sugar molecules across the plasma membrane. Specific carriers for different sugars are expressed in yeast. The uptake of maltose, for example, is dependent on the presence of a specific maltose permease. This carrier may exist in two forms distinguished by differences in maximal velocity (Vmax) and affinity constant (Km) Busturia and R. Lagunas, Biochim. Biophys.
Acta 820, 324 (1985)). The translocation of maltose across the yeast plasma membrane is coupled to the electrochemical proton {gradient in this membrane. For every maltose molecule taken up one proton is symported Serrano, Eur. J. Biochem. 80, 97 (1977)).
Intracellularly, maltose is hydrolyzed to two molecules of glucose in a reaction catalyzed by maltase (alpha-glucosidase). Glucose is subsequently converted to carbon dioxide and ethanol via the Embden-Meyerhof pathway. In comparison with the fermentation of glucose two additional
*I
-2 2 enzymes are required for the fermentation of maltoae viz.
i maltose permease and maltase. The synthesis of these enzymes is induced by maltose and repressed by glucose, fructose or mannose. In non-sugared ("lean") doughs maltose is the most abundant sugar available to yeast. In case sucrose is added to the dough this disaccharide is hydrolyzed extracellularly by yeast to glucose and fructose. Subsequently these hexoses are taken up by yeast by action of distinct permeases.
It is generally found that addition of sucrose to media containing maltose, as for example dough, inhibits the metabolism of maltose by yeast cells. This is due to the fact that transcription of genes encoding maltose permease and maltase is repressed by glucose Needleman, D.B. Kaback, R.A. Dubin, E.L. Perkins, N.G. Rosenberg, K.A. Sutherland, 15 D.B. Forrest and C.A. Michels, Proc. Natl. Acad. Sci. USA 81, S2811 (1984)).
Genes required for the uptake and hydrolysis of maltose are clustered in a MAL-locus Needleman et al.
S* Supra). Strains of Saccharomyces may contain up to five MALloci (MAL 1-4 and MAL which are unlinked and located at the telomers of different chromosomes Celenza and S* 4, M. Carlson Genetics 109, 661-664 (1985)). A MAL-locus comprises genes encoding maltose permease, maltase and one or more regulatory proteins (MAL regulator) required for the induction by maltose Needleman et al. Supra; J.D. Cohen, pi M.J. Goldenthal, T. Chow, B. Buchferer and J. Marmur, Mol.
SGen. Genet. 200, 1 (1985); R.A. Dubin, E.L. Perkins, R.B. Needleman and C.A. Michels, Mol. Cell. Biol. 6, 2757 (1986)). Said genes have been isolated and cloned (A.O.
J.D. Cohen et al., supra; R.B. Needleman et al., Supra; H.J. Federoff, J.D. Cohen, T.R. Eccleshall, R.B. Needleman, B.A. Buchferer, J. Giacalone and J. Marmur, J. Bacteriol. 149, 1064 (1982)).
As mentioned above yeast fermentation in lean dough depends on maltose as main substrate. Maltose is produced in the dough from starch by action of amylases, which are normally present in the flour. In addition, the flour contains a variable amount free sugars like glucose, raffinose I~ -i -~1 3etc. Suomalainen, J. Dettwiler and E. Sinda, Process Biochem. 7, 16 (1972)). These sugars are rapidly consumed by the yeast. Several studies have been published investigating the possible correlation between maltose fermentation and leavening activity of baker's yeast. In some cases a positive correlation was found between the rate of maltose fermentation with activities of maltase and maltose permease. However a positive correlation between the activities of maltase and maltose permease with leavening ability in lean dough could not be observed Hautera and T. Lovgren, J. Inst. Brew. 81, 309 (1975); T. Lbvgren and P. Hautera, Eur. J. Appl.
Microbiol. 4, 37 (1977)).
Transformation of yeast cells with multicopy plasmids containing genes encoding maltase and maltose 15 permease yielded a fourfold increase in specific activity of S. maltase but maltose permease activity was not enhanced.
Introduction of extra genes encoding the regulatory protein did result in a moderate increase in specific activity of 41 0 maltase but again no effect was observed on maltose permease activity Cohen et al., Supra). Obtained transformants were not assayed for carbon dioxide or ethanol production by these investigators. In fact prior art discouraged performing such tests since it had been shown repeatedly that there was no correlation between activities of maltose permease and maltase with carbon dioxide production (leavening activity) in lean dough Suomalainen, J Dettwiler and E. Sinda, Supra; II. Suomalainen, Eur. J. Appl. Microbiol. 1, 1 (1975); P. Hautera and T. LSvgren, Supra; T. L6vgren and P. Hautera, Supra).
We have now found that yeasts, transformed by integrative plasmids of which examples will be described hereafter, show an enhanced level of maltose permease and maltase activity, compared to the untransformed strain. These enhanced maltase and maltose permease activities surprisingly coincide with an increase of C02 production or leavening activity, as was also observed in case of yeast transformed with episomal vectors.
These improved yeasts show higher rates of metabolism resulting in for example higher carbon dioxide and ethanol production in media containing sugars, such as maltose, as main carbon and energy source. The methods provided involve application of recombinant DNA techniques in such a way that the rate of maltose fermentation by said yeasts is increased drastically irrespective of the presence of other sugars as for example glucose.
Furthermore these improved yeast strains show an excellent leavening activity (gas production) in dough.
Analogously, the higher rate of ethanol production of these yeasts will result in a reduced fermentation time for yeast employed in the production of potable and industrial alcohol or a larger amount of alcohol produced in a certain time.
Furthermore in case (accumulation of) maltose is inhibiting enzymes, which convert sugar or starch, rapid removal of maltose is advantageous for said fermentation process. By applying the process of the present invention a yeast can be obtained in which (an) extra gene(s) is (are) introduced encoding maltase and/or maltose permease.
The present invention provides a transformed yeast and *o a process to produce said yeast improved in the fermentation rate of sugars which comprises the introduction into yeast of at S least one, preferably homologous, DNA construct which comprises at least one gene in said yeast encoding a protein promoting the S uptake and/or initial metabolic conversion of a transported substrate, the gene being capable of expression in said yeast.
The rate of fermentation of sugars can be improved during several phases of the leavening, for example an enhanced rate caused by the fermentation of maltose or sucrose.
By homologous DNA is meant DNA originating from the same yeast genus. For example Saccharomyces is transformed with DNA originating from Saccharomyces. In this way it is possible to improve already existing properties of the yeast genus, without introducing new properties, which were not present in the genus before. The improvement of fermentation rate of sugars may be obtained under aerobic and/or anaerobic conditions. The genes of interest include permeases, particularly maltose permease, saccharidases, particularly maltase, kinases, particularly 39 hexokinases and glucokinase, and the like. This invention may 1 be applied, for example, for a carrier protein required for the uptake of glucose or fructose and hexokinases and glucokinase which catalyze the initial intracellular metabolic conversion of these hexoses to hexose phosphates.
The present invention also provides efficient methods for introduction into the yeasts of at least one homologous DNA construct.
Advantageously the invention may be applied to a construct which comprises at least one gene which encodes a protein which promote the uptake of maltose and the initial metabolic conversion of maltose to glucose. In this way yeasts can be obtained which have several advantages in comparison with the original (host) strains. The benefits of such improved yeast may be found particularly in the improved ethanol and CO 2 production. For example when the invention is applied to °o°0 baker's yeast this will be an enormous advantage for a baker o°o because the baker requires less time or less yeast in order to 0*O develop lean dough because of the improved leaving activity of the novel strains.
26 It will be appreciated that the transformed yeast according to the invention can be used as starting strain in strain improvement procedures other than DNA mediated transo. formation, for instance, protoplast fusion, mass mating and mutation. The resulting strains are considered to form part of 0" the invention.
According to a preferred embodiment of the invention the novel strains will consume substantial amounts of maltose in the presence of glucose. Therefore bakers may save on sugar :0 expenses as well, since less sugar needs to be added to obtain sweet doughs.
It is well-known that osmotolerant yeasts show a poor performance (leavening activity) in lean dough. By osmotolerant yeasts is meant yeasts which have a good performance in sweet doughs. Doughs for sweet bakery goods will contain for example 10-30% sugar (based on flour weight). Therefore, when an osmotolerant strain is chosen as a host to be transformed according to the invention an osmotolerant yeast is obtained which not only is applicable in sweet doughs but may also be 39 used in lean dough since its capacity to ferment maltose is GD ~ajnsaroarru~--- improved according to the invention. As a consequence the baker conveniently requires only one type of yeast both for sweet doughs and for lean doughs.
The need for yeast strains that have a good performance in lean as well as in sweet doughs is for example described in EP-A-128524 and DE-A-2757778. To obtain yeast strains which have a good performance in sugar rich and lean dough, EP-A- 128525 describes a protoplast fusion method: DE-A-2757778 describes in order to obtain such yeast strains a selection method of strains from a population of diploid strains prepared by hybridization or mutation methods. Both procedures need a lot of experimentation and the results are unpredictable and not i o 0 0 L- -6reproducible. By using the process of the present invention, controlled and reproducible results with the transformed yeast strains can be obtained. The testing of the strains produced according to the invention can be minimal because the properties of the strain itself are substantially not altered except for the improved properties as disclosed.
The present invention provides a compressed yeast which shows a gas production of at least 340 ml/285 mg dry weight of yeast in 165 minutes in Test B and a gas production of at least 170 ml/285 mg dry weight of yeast in Test B'.
Tests B and B' are described hereinafter. Preferably the compressed yeast shows a gas production of 380-450 ml/285 mg dry weight of yeast in 165 minutes in Test B and 180- 240 ml/285 mg dry weight of yeast in Test B' and more preferably at least 400 ml/285 mg dry weight of yeast in Test B and at least 190 ml/285 mg dry weight of yeast in Test respectively. Advantageously instant dry or active dry yeast is prepared from this compressed yeast. During drying of the compressed yeast generally 15-25% of the leavening activity based on dry matter is lost. The present invention also provides a dried yeast (3-8 wt% moisture) which shows a gasproduction of 310-360 ml/285 mg dry weight of yeast in 165 minutes in Test C and 145-195 ml/285 mg dry weight of yeast in Test C' and preferably at least 330 ml/285 mg dry weight of S: 25 yeast in Test C and at least 155 ml/285 mg dry weight of yeast in Test respectively. The gas values obtained with yeast prepared according to the invention have never been found even when commercially available strains were tested in Tests C and The invention can also be applied for yeasts which show a good performance in leavening activity in the range of 0-6 or J 0-10% sugar dough. In this way it is possible to prepare compressed yeasts which show a gas production of 400-500 ml/285 mg dry weight of yeast in 165 minutes in Test B, preferably these compressed yeasts show a gas production of at i least 440 ml/285 mg dry weight of yeast. Dried yeasts can then be obtained which show a gas production of 320-400 ml/285 mg
M
11 7 dry weight of yeast in 165 minutes in Test C, preferaoly the Sried yeast shows a gas production of at clast 350 25 S'y weight of yeast.
Similar advantages of tnese novei trains r' 53 i: farnentations for the production of potable and induCtria_ alcohol.
Since the overall metabolic ra'e ;cc r strains has been increased when maltose serves as a sub*tra ,e the overall production rate of metabolites such as glyceroi and aroma compounds willbe increased as well.
In one aspect of the invention vectors are provided bearing a DNA construct encoding one or more proteins involved in maltose fermentation. The present invention also provides a microbial host, preferably a yeast, which is, for example, a species of Saccharomyces transformed with vectors disclosed oy 1 4the invention. These vectors may be self-replicating and 4 contain advantageously a gene, or combinations of gei.es, selected from those encoding maltose permease, maltase and maltose regulatory protein. Surprisingly, it has been found that yeast, transformed with such vectors, shows an enhanced rate of maltose fermentation, which results in an increased rate of C02 production in dough. These additional genes are 4 located on episomes, however, and it is known from literature that such extrachromosomal molecules are easily lost during non-selective propagation growth in the absence of G418 in this particular case) Hollenberg (1982) Gene Cloning 12, Organisms other than E. coli, Eds. P.H. Hofschneider, W. Goebel, Springer Verlag, 119; S.A. Parent, C.M. Fenirone, and K.A. Bostian (1985), Yeast 1, 83). From a practica. poi'nt of view it is preferred to cultivate yeast non-selectively and therefore a set of integrating plasmids containing, preferably altered, maltase and/or maltose permease genes are advantageously constructed. By "altered" is meant the exchange of the natural promoter by another promoter. preferably honc:logous. In 3: case processes are developed which allow stable pt. 1: of plasmids in the absence of a selective pressure,
;I
ii j integration of newly introduced DNA is not a prerequisite anymore in order to obtain stable transformants.
It is known from literature that one cell contains between 20-100 molecules of these extra plasmids Hollenberg (19b2), Supra; A. Takagi, E.N. Chun, C. Boorchird, S. Harashima and Y. Oshima. Appl. Microbiol.
Biotechnol. 23, 123; J. Mellor, M.J. Dobson, N.A. Roberts, N.J. Kingsman and S.M. Kingsman (1985) Gene 33, 215).
The level of expression of episomal genes may be increased even further by exchange of the original promoters by stronger promoters. It seems likely that in the future it will be possible to allow stable replication of plasmids in the absence of a selective pressure.
The maltase and/or maltose permease genes are S 15 according to the invention advantageously integrated into the yeast chromosome via transformation with linear plasmids (see T.L. Orr-Weaver, J.W. Szostak, R. Rothstein (1981) Proc. Natl.
"I Acad. Sci. U.S.A. 78, 6354). The obtained yeasts are stable transformants, i.e. altered maltase and/or maltose permease genes can be maintained in the genome even in the absence of selective pressure.
It is known, that during integration only one or a Sfew copies of genes located on a plasmid become integrated into the chromosome. Therefore, in order to obtain similar improvements in C02 production as obtained when episomal vectors are used, the level of gene expression may be advantageously altered by application of strong constitutive promoters, not sensitive to glucose repression. Such promoters are preferred in order to compensate for the difference in gene copy number between yeast transformed with episomal and with integrative vectors, and in order to prevent the effects of glucose-respression. It is observed, for instance, that during the first 30-40 minutes of fermentation in media containing maltose as main carbon and energy source and relatively low concentrations of glucose, mRNA levels of maltose permease and maltase decline to barely detectable levels. Once the glucose ha:s been consumed, inouction of' ;ecnt.
-jression bv maltose results in a raTp-d Increp o 3r y;n As indicated, the geies may oe uae~ ih ei i,-itiirai. )t wild-tI-ype pcrmoter or tho promo!>er 'Ialy be 2ubi, h *t it kit ed w ith' a d if fe r e rt P-r p re f c a 'D-Ly Kiiromoter Earticular ly where th -aiIl tyoe -rnoiter -L regulatable or inducible, it may be Jesirable to prc'Jrli constitutive transcription, or a stronger or weaker pr-)-;m-er.
ic 2,onversely, where the wild-type promoter is constitLzv'r, may be of interest to provide for a regulatable or inducJ-ble *0 promoter or a stronger or weaker promoter.
Desirably, strong promoters will be employed, 0 particularly where there may be a relatively low copy number 15 of the construct in the nost. -togpooeswl Ly be those involved with the production of proteins r>co high level during the life cycle of the yeast or where regulatable, at some period of interest the life cyc-Le the yeast, as related to the subject invention.
Promoters associated w'-th the zlyc, lyt-ic cyc-e c'-f yeast are of particular, interest, which 'nclude alcohol dehycirogenase I and II, phosphoglucoisomerase, glucose-bphios phate dehydrogenase, -ric se, phosphate isomerase, Lyceraldehydephosphate dehydrogeniase, phosplhoglyce:,- te kinase, enolase, phosphoglyceromutase, pyruvate kinase, and Lactate dehydrogenase. Other promoters involved with -rotei.
produced in high amoun-t, include promoters associated wi-4-h rlbosomal expression, such as promoters for the tasrpif initiation factors, elongation factors, and tne -'ke.
Particular elongation factors include EF-l and EF-2, etc.
Of Particular interest is the use of promoters in combination with structural genes involved with maltose metabolism, particularly maltase, maltose permease and MAL-regulator.
These promoters may be constitutive or regulatable, s lcn.- -!Z -,ha promoter is induced d-iring the fermentation cf-. For example, many of the glycolytic promoters are iaed In the presence of a sugar or a sugar metabolite, such as ethanol. Thus, promoters such as alcohol dehydrogenase wil* be active during the leavening of flour. Similarly, those promoters associated with cell proliferation will also be active during the leavening of dough. Furthermore, by providing for promoters which are not regulated by the MAL regulator, the yeast may be used in the presence of glucose, without repression. In addition, the genes do not require maltose for induction.
Where the wild-type promoters are employed in conjunction with the structural genes of interest, it may be desirable to provide for enhanced production of a regulatory protein. In this way, the regulatory protein may be maintained at a high level, when the inducer is present. For example, in 15 the presence of maltose, the MAL regulatory protein will be expressed at a high level, so as to provide for expression of o the other proteins associated with maltose metabolism and regulated by the MAL regulatory protein.
The alterations in gene expression, as described in 20 detail in the- experimental procedures, comprise the exchange of the original promoters plus (part of) the untranslated leader sequences for those of alcohol dehydrogenase I (ADHI) and translation elongation factor EFlaA preferably derived from the host yeast, for example Saccharomyces. As a consequence, expression will become insensitive to glucose repression and independent of maltose for induction.
It has been found that yeasts, transformed by these integrative plasmids show an enhanced level of maltose permease and maltase activity compared to the untransformed strain. These enhanced maltase and maltose permease activities surprisingly coincide with an increase of C02 production or leavening activity, as was also observed in case of yeast transformed with episomal vectors.
The obtained improvement in leavening activity is maintained during storage even at elevated temperatures, for example, at 20-25°C. The relative loss of leavening activity 11 during storage is virtually identical for the paretal ~C~ra-i inu the strains acoriing to the invention. Thi' iea'.nilg activity in 'igh sugar dougns i" not aff' o.
introduced modifications since the leavening activity of the novel strains transformed with integrative plasmids is as good as that obtained with the host strain.
The subject yeast host will have i*,s .E of the construct, and may have two or more, usually not exceeding about 200, depending upon whether the gene is integrated into the genome, amplified, or is present on nr extrachromosomal element having multiple copy numbers.
Integration or non-integration may be selected, depending upon the stability required for maintenance of the extrachromosomal element prepared, the number of copies desired, the level of transcription available depending upon copy number, anc the like.
The construct may include one or more structiral genes with the same or different promoters. The construct may be prepared in conventional ways, by isolating the oesired genes from an appropriate host, by synthesizing all or a portion of the genes, or combinations thereof. Similarly, the regulatory signals, the transcriptional and translational initiation and termination regions, may be isolated from a natural source, be synthesized, or combinations thereof. The various fragments may be subjected to endonuclease digestion (restriction), ligation, sequencing, in vitro mutagenesis, primer repair, or the like. The various manipulations are wel known in the literature and will be employed to achieve specific purposes.
The various fragments may be combined, cloned, isolated and sequenced in accordance with conventional ways.
After each manipulation, the DNA fragment or combination of fragments may be inserted into the cloning vector, the vector transformed into a cloning host, e.g. E. coli, rhe cl~uin 3D ust grown up, lysed, the plasmid isolated and The fL T analyzed by restriction analysis, sequencing, combinations thereof, or the like.
-II r 12 Various vectors may be employed during the course K of development of the construct and transformation of the host i cell. These vectors may include cloning vectors, expression vectors, and vectors providing for integration into the host or the use of bare DNA for transformation and integration.
The cloning vector will be characterized, for the most part, by having a replication origin functional in the cloning host, a marker for selection of a host containing the cloning vector, may have one or more polylinkers, or additional sequences for insertion, selection, manipulation, ease of sequencing, excision, or the like. In addition, shuttle vectors may be employed, where the vector may have two or more origins of replication, which allows the vector to be replicated in more than one host, e.g. a prokaryotic host a id 15 a eukaryotic host.
i* Expression vectors will usually provide for insertion of a construct which includes the transcriptional and translational initiation region and termination region or the construct may lack one or both of the regulatory regions, which will be provided by the expression vector upon insertion of the sequence encoding the protein product. Thus, the construct may be inserted into a gene having functional transcriptional and translational regions, where the insertion is proximal to the 5'-terminus or the exising gene and the construct comes under the regulatory control of the existing regulatory regions. Normally, it would be desirable for the initiation codon to be 5' of the existing initiation codon, unless a fused product is acceptable, or the initiation codon is out of phase with the existing initiation codon. In other 1 30 instances, expression vectors exist which have one or more restriction sites between the initiation and termination regulatory regions, so that the structural gene may be inserted at the restriction site(s) and be under the reulatory cqntrol of these regions. Of particular interest for the subject invention as the vector for expression, either for extrachromosomal stable maintenance or integration, are
I
c~ IILhJ4. 4VJ. pt-I...k4JIU±LI~ 4.1 4ShLLJIL L~~CL 6003q/ 1 constructs and vectors which in their stable form in the host are free of heterologous (non-Saccharomyces) DNA.
SAccording to a further aspect of the invention processes are provided to produce yeasts which exhibit all the advantages described above whereas in addition prokaryotic DNA sequences have been removed. This has been accomplished by gene replacement techniques Rothstein (1983) Methods in Enzymology, 101, 202). According to the present invention these techniques are now advantageously applied to Saccharomyces cells.
For example, transformation of Saccharomyces cells with a vector containing genes encoding altered maltase and/or maltose permease located in a Saccharomyces sporulation-specific gene Gottlin-Ninga, D.B. Kaback (1986) Mol. Cell. Biol. 6, 2185).
After introduction of this DNA into a Saccharomyces host cell homologous recombination of the newly introduced DNA takes place S with the chromosomal sporulation-specific gene. As a consequence altered maltase and/or maltose permease genes embedded between the sporulation specific sequences become integrated into the chromosome. Resulting transformants are completely devoid of prokaryotic
DNA.
It will be appreciated to realise that even better results may be obtained if the optimal ratio of maltase and maltose permease activity is determined. This can be done by varying the promoters of both genes or by integration of S different numbers of (altered) maltase and maltose permease genes into the yeast genome, for example, by using several integration loci, according to methods as described below. The optimal ratio of maltase and maltose permease activity can also be obtained using maltase or maltose permease genes encoding other isoenzymes of maltase and maltose permease. Furthermore any enzyme can be applied, having at least maltase or maltose j permease activity. In addition, genes encoding the MALregulatory protein can be integrated into the genome in an analogous way (see also Example either under control of its own, natural promoter or under control of another promoter, preferably Saccharmomyces. This can also be useful in order to obtain an optimal ratio of maltase and maltose permease 38 activity.
-13- If 14 List of deposited strains The following strains have been deposited with the j Centraal Bureau voor Schimmelcultures, Baarn, Holland: Saccharomyces cerevisiae 237 Ng (strain A) has been deposited with the CBS under the accession number 158.86 on March 25, 1986; Saccharomyces cerevisiae DS 15543 (strain C) has been deposited with the CBS under the accession number 406.87 on September 3, 1987; Escherichia coli harbouring plasmid p21- 4 0 has been deposited with the CBS under the accession number 400.87 on 2' August 28, 1987; S 15 Escherichia coli harbouring plasmid pYEF46 has been deposited with the CBS under the accession number 401.87 on August 28, 1987; Escherichia coli harbouring plasmid pY6 has been deposited with the CBS under the accession number 402.87 on 20 August 28, 1987; Escherichia coli harbouring plasmid peG418 has been deposited with the CBS under the accession number 160.8b on 'l March 25, 1986; Escherichia coli harbouring plasmid pTZ19R has been deposited with the CBS under the accession number 405.87 on September 3, 1987; Escherichia coli harbouring plasmid pTZ19R/ADHI has been deposited with the CBS under the accession number 404.87 i on September 3, 1987; Escherichia coli harbouring plasmid p153-215 AK has been deposited with the CBS under the accession number 403.87 on September 3, 1987.
Escherichia coli harbouring plasmid pLF24 has been deposited with the CBS under the accession number 156.88 on March 8, 1988.
i i 1 -I i: 14l :4 4 I i4 .4 .1 44,, 15 Escherichia coli harbouring plasmid pUT332 has been deposited with the CBS under the accession number 158.88 on March 8, 1988.
Escherichia coli harbouring plasmid pTZ18R haa been deposited with the CBS under the accession number 480.88 on July 27, 1988.
Brief description of the Drawings Figure 1 describes the construction of plasmid pGb-eMAL69. Arrows indicate the direction of transcription of indicated genes. Plasmids are drawn schematically and not to scale. Abbreviations: G418, Tn5 gene (under control of ADHI promoter) conferring resistance to G418; P, Pvul; X, Xbal; S, 15 Sail; H, HindIII; CIP: calf intestine phosphatase.
Figure 2 describes the construction of pGb-eMAL61.
Plasmids are drawn schematically and not to scale.
Abbreviations: A maltase partial deletion maltase gene; B, BglII. See also description of Fig. 1.
Figure 3 describes the construction of plasmid pGb-eMAL63. Plasmids are drawn schematically and not to scale.
Abbreviations: filled-in KpnI site; filled-in Sail site; Klenow, large subunit DNA polymerase; H, HindIII. See also description of Fig. 1.
Figure 4 describes the construction of pGb-M6g(A Abbreviations: H, Hind III; St, Stul; Klenow, large fragment DNA polymerase I; EV, EcoRV; Xh, XhOI; M, Mlul; fl ori, origin of replication phage fl; amp, ampicillin resistance gene; s.p. sequence primer.
Arrows indicate 5' 3' direction. Deleted area is indicated with dotted lines and A t t t I t i '1 s I.
I 16 Figure 5 describes the sequence of plasmid j pGb-M6g( a) maltase and maltose permease genes. Arrow indicates direction of transcription. St (Stul) served as startpoint for construction of deletion mutant. Relevant parts of sequence of intergenic area are shown below this map.
b) Sequence of pGb-m6g Deleted area extends from -9 to -417. Polylinker refers to the oligonucleotides which have been ligated onto the Bal31-treated DNA (see also Fig. 4).
Figure 6 describes the construction of plasmid pGb-iA32/G418. Arrows indicate direction of transcription.
'Plasmids are drawn schematically and not to scale.
S 15 Abbreviations: H, Hind III; EV, EcoRV; fl ori, origin of replication phage fl; amp, ampicillin resistance gene; G418, Tn5 gene (ADHI promoter) conferring resistance to G418; S, Smal; He, HinclI; pADHI, promoter alcohol dehydrogenase I gene part 5'leader (hatched area).
Figure 7 describes the construction of plasmid I i e pGb-iRROl a) plasmid pT4 is not drawn to scale.
Abbreviations: E, EcoRI; B/Bg, BamHI/BglII ligation; H, HindIII b) mutagenesis on pT4 in order to fuse the EFlaA promoter 5'leader to the five N-terminal amino-acids codons of the maltase gene in such a way that a BglII site is created as well. Relevant sequences are shown.
Mutagenesis primer is partly complementary (indicated with dots) to the EFlaA sequence. In the region of mismatches are the maltase codons and the -boxed- BglII recognition site (note that the presented orientation of the mutagenesis primer is i.e. the BglII site should be read from right to left In the maltase sequence the N-terminal five amino acid codons are indicated. The Bcll recognition site is boxed.
L~
17 S- In the sequence of pT4-M, the sequence covering the mutation is shown. BglII site is boxed. Asterisks indicate i the deviation from the maltase nucleotide sequence. The deviation in the fourth codon is a silent mutation.
c) Plasmids are not drawn to scale. Abbreviations: H, HindIIl; Bc, Bcll; E, EcoRI; Bg, BglII; EV, EcoRV; Bg/Bc, BglII/BclI ligation; pEFlaA (hatched box), 5' flank (promoter 5'leader sequence) of EFlaA; fl ori, origin of replication of phage fl; amp, ampicillin resistance gene.
d) Plasmids are not drawn to scale. Abbreviations: see c).
Figure 8 describes the construction of plasmid pGb- SNENS. Plasmids are drawn schematically and not to scale.
Abbreviations: E, EcoRI; H, HindIII;Sf, Sfil; N, NotI; fl ori, origin of replication phage fl; amp, ampicillin resistance gene. Arrows indicate 3' direction. Oligo 3 and 4 are synthetic oligodeoxynucleotides with the base sequence as indicated.
Figure 9 describes the contruction of plasmid pGb- RB2. Plasmids are drawn schematically and not to scale.
Abbreviations: E, EcoRI; Bg, BglII; H, Hind III; Hc, HinclI; B, Bam VI; Sm, Sma I; P, Pst I; fl ori, origin of replication phage fl; amp, ampicillin resistance gene. Arrows indicate 3' direction. Oligo 5 and 6 are synthetic oligodeoxynucleotides with the base sequence as indicated.
Underlined are the TAA translational stopcodons in all reading frames.
Figure 10 describes the construction of plasmid pGb RBN 3. Arrows indicate direction of trancription. Plasmids are drawn schematically and not to scale. Abbreviations: Sf, Sfil; Sm, Sma I; H, Hind III; fi ori, origin of replication phege fl; Amp, ampicilline resistance gene; G418, Tn5 gene (under control of ADHI promoter) conferring resistance to G418. EV, EcoRV; He, Hinc II.
-18 Figure 11 describes the construction of plasmid pGb-RBRRO1. Plasmid pGb-iRROl is fully described in Figure 7 i and contains the maltase gene under direction of EFluA promoter (pEFlaA) and the maltose permease gene under direction of the alcohol dehydrogenase I promoter (pADHI) (both promoters are indicated with hatched boxes). pGb-RB2 is described in Figure 9. In pGb-RBRRO1 the SIT4 containing fragment is divided into two parts ("SIT4 flanks"). Plasmids are drawn schematically and not to scale. Abbreviations are as in legends to Figure 10. Arrows indicate drection of transcription.
4 4 o SFigure 12 describes the one-step gene disruption.
i In step 1, pGb-RBN3 is digested with Sfil. This liberates a 15 DNA fragment which has on both sides homology to the SIT4 gene region. This directs integration to the SIT4 gene (see also R.J. Rothstein (1983) in Methods in Enzymology, 101, 202). The SIT4 gene region is indicated by a hatched box. Both chromosomal alleles have been shown schematically. In step 2, S 20 the resulting strain ApGb-RBN3 is transformed with both pUT332 (undigested) and pGb-RBRRO1 digested with Sfil. The principle of cotransformation is well documented (cf. A.H. Brand, I.
Breeden, J. Abraham, R. Steiglanz and K. Kasmyth (1985) Cell 41, 41-48 and P. Siliciano and K. Tatchell (19b4) Cell 37, 969-978) In the first selection we have used resistance ii against phleomycin (plasmid pUT 332) but of course 2a-derived episomal plasmids conferring resistance to other antibiotics like hygromycin B can be used as well. PUT332 and phleomycin are commercially available from Cayla, Avenue Larrien, Centre I 30 Commercial de Gros, 31094 Toulouse C6dex, France. On pUT 332, :at the phleomycin-resistance gene is derived form transposon and has been placed under the direction of a yeast promoter.
In step 3 the episomal plasmid pUT332 is removed from the transformants by growth in non-selective medium (curing).
Abbreviations: G418r, G418 resistance gene.under direction of ADHI promoter; Sf, end of a DNA fragment generated by Sfil 11 :i 19 digestion; MAL, an altered maltase and maltose permease gene.
See also Fig. 9 and 11 for details of the plasmids; +pUT332, j episomal plasmid pUT332.
Figure 13 describes the correlation between the increase in specific activity of maltose permease and ima ase with the disappearance of glucose from meuaium A. Granhs are typical for commercial baker's yeast strains as for example strain A.
Figure 14 describes the specific activities of maltose permease in strain A and its rDNA derivatives during a simulation of dough-rise in medium A.
a u S 15 Figure 15 describes the specific activities of maltase during a simulation of dough-rise in strain A and its rDNA derivatives in medium A containing maltose as main carbon and energy source.
S 20 Figure 16 describes the fermentation of maltose during a simulation of dough-rise by strain A and its rDNA derivatives in medium A containing maltose as main carbon and energy source.
Figure 17 describes the fermentation of maltose during a simulation of dough-rise by strain A and its rDNA derivatives in medium B containing glucose as main carbon and energy source.
The following experimental data are given to illustrate the invention. It has to be understood that a person skilled in the art who is familiar with the methods may use other yeast strains and vectors which can be equally used for the purpose of the present invention. These alterations are .ncluded in the scope of the invention.
i, I- i -~~--uuiu i C- i i' ;j i Ij j j i Ij 1 i
I~
i 20 Cloning techniques For general cloning techniques reference is made to the handbook of Maniatis et al. Maniatis, E.P. Fritsch, 5 J. Sambrook (1982) Molecular Cloning, A Laboratory Manual).
Restriction enzymes are used as recommended by the manufacturer and are obtained either from New England Biolabs (Biolabs), Bethesda Research Laboratories (BRL) or Boehringer Mannheim (Boehringer). In general 1 to 5 units of enzyme are needed to cleave 1 ug of DNA.
Transformation of E. coli was carried out using the CaCl 2 -technique Maniatis et al., Supra).
Construction of recombinant plasmids i i i -i i 1) pGb-eMALbg This plasmid is capable of self-replicating in yeast and contains the genes encoding maltose permease and maltase. Its construction is outlined in Fig. 1.
peG418 is derived from pEMBLYe23 (Baldari and G.
Cesarini (1985), Gene 35, 27) and contains between the Sall and HindIII sites a fragment with the Tn5 gene (Reiss et al.
EMBO J. (1984) 3, 3317) conferring resistance to G418 under di.cction of the promoter alcohol dehydrogenase I (ADHI) from 25 yeast, similar to that as described by Bennetzen and Hall Bennetzen and B.D. Hall (1982) J. Biol. Chem. 257, 3018). peG418 was cleaved with HindIII, dephosphorylated with CIP and ligated with a digest of pY6 x HindIII x Pvul. pY6 is described Needleman and C. Michels (1983) Mol. Cell.
Biol. 3, 796; R.B. Needleman, D.B. Kaback, R.A. Dubin, S.L. Perkins, N.G. Rosenberg, K.A. Sutherland, D.B. Forrest, C. Michels (1984) Proc. Natl. Acad. Sci. U.S.A. 81, 2811) and contains a 7.0 kb HindIII fragment comprising the MAL6g locus.
This yielded pGb-eMAL6g.
i t- 21- 2. pGb-eMAL61 V This 2k-derived episomal plasmid contains the gene encoding maltose permease. Its construction is outlined in Fig. 2.
pGb-eMAL6g contains two BglII sites, both lying in the maltase gene. This 1.4 kb BgllI ha. been deleted from pGbeMAL6g by digestion with BglII, followed by dilute religation to promote intramolecular ligation. Such a deletion has been shown to destroy maltase function Cohen, M.J. Goldenthal, T. Chow, B. Buchferer and J. Marmur (1985) Mol. Gen. Genet. 20, 1).
3. pGb-eMAL63 This 2p-derived episomal plasmid contains DNA covering the MALp function (regulatory protein gene or MALregulator). Its construction is outlined in Fig. 3.
From p21-40 Needleman and C. Michels (1983), 1.4 S 20 Supra) the Kpnl-SalI fragment was isolated containing the regulatory protein gene. This fragment was made blunt-ended using T4 DNA polymerase and the Klenow-DNA polymerase and thereafter cloned into the filled-in HindIII site of pe418b.
4. pGb-M6g(-9) This plasmid is a promoter-deletion mutant made in the intergenic region of the divergently transcribed genes maltose permease and maltase (see Fig. This region contains the promoters for both genes Hong and J. Marmur (1986) Gene 41, 75). This deletion mutant has been made in order to replace the original promoters. The construction comprises the following steps: a) The approximately 7.0 kb HindIII fragment containing the genes for maltase and maltose permease (see 22 also Fig. 1) was cloned into the HindIII site of pTZ19R. This i plasmid is commercially available (Pharmacia). This results in pGb-M6g.
b) pGb-M6g was linearized with Stul, which cuts in the intergenic region. The Stul-generated ends served as starting point for the exonuclease Bal31 in order to nibble off (parts of) the promoters-containing intergenic area. StuI lies closer to the maltose permease gene Hong and J. Marmur (1986), Supra). The Bal31 incubation wap carried out as described by Maniatis et al Maniatis, E.F. Fritsch and J. Sambrook (1982), Supra). At appropriate times samples have been removed from the reaction and incubated with Klenow DNA S polymerase to make blunt-ends. Then synthetic linkers have been ligated onto the ends containing several restriction S sites.
The following complementary oligodeoxynucleotides have been used: 20 1. 5' GATATC CTCGAG AGGCCT A 3' 2. 3' CTATAG GAGCTC TCCGGA TGCGC In double-strand form restriction sites are created for EcoRV (GATATC), Xhol (CTCGAG), Stul (AGGCCT), ligation at the sticky end creates a Mlul site (ACGCGT). After kinase-reaction, the linkers have been ligated onto the Bal31 treated DNA, Saccording to conditions as described Maniatis et al., (1982) Supra). The reaction mixture was then incubated with Mlul and chromatographed through a 5 ml Sepharose C1-2B column in order to separate the non-ligated oligodeoxynucleotides from the DNA fragment. Fractions containing this linear DNA were pooled, ligated to plasmid DNA and introduced into bacteria.
c) The resulting set of deletion mutants were subjected to sequence analysis. To this end, the double-
SI.
23 stranded plasmids were converted into single-stranded DNA by superinfection with a helper phage (protocol accordijig to recommendation of supplier). The single-straned templates were extracted by normal M13 procedures for use in diaeoxysequencing Sanger, S. Nicklen and A.R. Cculson (i977) Proc. Natl. Acad. Sci. 74, 5463). As a primer we have used a synthetic oligodeoxynucleotide (5'-GAATTCGGTAGCGTTCACGC-3'), complementary to a stretch of DNA near the ATG startcodon of the maltose permease gene. Its orientation is such that the sequence is read towards the promoter (see also Fig. 4).
The deletion mutant in which most of the maltose permease promoter had been removed, was selected for further experiments. (Part of) the maltase promoter is still present (note that the StuI site as startpoint for exonuclease S ;treatment is located asymmetrically in the intergenic region).
Fig. 5 lists the sequence at the deletion point of the mutant pGb-M6g(A-9). This is compared to the recently determined sequence of this entire area Hong and J. Marmur (1986) Supra). In the wild type sequence, one difference has been Sobserved with the published sequence: the C at -878 (numbering according to S.H. Hong and J. Marmur (1986) Supra) is not present in our sequence. In accordance, the DNA cannoc be digested with Hpal or HincIl at this position.
Plasmid pGb-M6g(6-9) is the starting plasmid to fuse other promoters to both the maltose permease gene and the maltase gene (see below).
pGb-iA32/G418 This plasmid is an integrating yeast plasmid. It contains the maltose permease gene, hooked onto the alcohol dehydrogenase I promoter and part of its 5'leader sequence.
Its construction was as follows (Fig. 6).
a) Plasmid pTZ19R/ADHI contains a 1.4 kt BanmiI fragment with the ADHI promoter, starting at position 1.
24 relative to the AUG codon Bennetzen and B.D. Hall (1982) J. Biol. Chem. 257, 3018). From this plasmid, the 700 bp EcoRV-HincII fragment has been isolated and ligated to EcoRV digested pGb-M6g Resulting plasmids were analysed with restriction enzyme digestions and the proper orientation was confirmed via dideoxy sequence analysis on single-stranded templates (see Fig. The same oligoprimer was used as described in section 4c.
As a result of the cloning procedure of the ADHI promoter fragment, part of the polylinker of pTZ19R (BamHI- HincII) is present between tbe maltose permease gene and the ADHI promoter. Structure and sequence of pGb-A32 is shown in Fig. 6a.
b) Plasmid pGb-A32 was provided with the dominant selection marker G418res. A 1.9 kb EcoRV/HincII fragment contains the Tn5 gene conferring resistance to G418 under direction of the promoter alcohol dehydrogenase I. This S fragment was isolated by an EcoRV/HincII double digestion of plasmid 153-215 AK. The EcoRV/HincII fragment was cloned into the Smal site of pGb-A32. This yielded pGb-iA32/G418.
6. pGb-iRRol 4 *This plasmid is an integrating plasmid. It contains the maltose permease gene under direction of the promoter alcohol dehydrogenase I and the maltase gene under direction of the promoter translation elongation factor EFlaA. The cloning pathway is depicted in Fig. 7. The approach was as follows: The maltase gene contains a Bcll site around the fifth amino acid codon. Therefore the EFlaA coding region was mutagenized in such a way that the first five amino acids became identical to those of the maltase protein. A BglII site was co-introduced at the position of the Bcll site.
Conversion of a Bcll site to a BglII site is a silent mutation in the fourth codon. Via a BglII/BclI ligation the EFlaA promoter and leader sequence could be fused to the rest of the maltase gene. The procedure comprised the following steps: L analyzed by restriction analysis, sequencing, combinations thereof, or the like.
25 a) The starting plasmid was pYEF46 Nagata, K. Nagashima, Y. Tsunetsugu-Yokota, K. Fuyimura, M. Miyaraki ana Y. Kaziro (198K E I' O J. 3, 1025) which contains the entire gene coding for EFlaA. A 2.5 kb BglII fragment covering this gene, was isolated and cloned into the BamHI site of pTZ19R. Clone pT4 was picked up (see Fig. 7a) and used for the oligoaeoxynucieo ide directed mutagene.is.
b) After superinfection with helper phage, single stranded (ss) DNA of pT4 was isolated. 400 ng ss DNA, 400 ng heat-denatured pTZ19RxBamHI and 100 ng mutagenesis oligodeoxynucleotide (see Fig. 7b) were incubated in a volume of 10 Ll of 7 mM Tris HC1 pH 7.5; 50 mM NaCI and 7 mM MgCl2 for 10 minutes at 5600. After 10 minutes at room temperature, second strand synthesis and ligation were started by additio, of 1 ul of Klenow DNA polymerase 1 al of T4 DiA ligase 1 pl TMD (200 mM Tris HC1 pH 7.5, 100 mM MgCl2, 100 mM DTT), 4 ul 2.5 mM dNTP-mix, 1 ul 10 mM ATP and 2 Il H20. Endvolume was 20 pl, incubation was performed for 16 hours at 17°C, after which the mixture was transformed to E. coli JM101. Mutants were screened by colony hybridization with a kinased oligodeoxynucleotide, specific for the mutant (see Fig. 7b). This screening oligomer 5'-GACTATTTCAGATCTTC-3' was complementary to the introduced maltase codons and flanking nucleotides. The hybridization was carried out for 16 hours in 6 x NET (1 x NET 0.15 M NaCl, 0.015 i Tris HC pH 0.001 M EDTA) at 25°C. Post-hybridization washes were performed in the same mix at the same temperature (3 times minutes), followed by a wash in 3 x NET at 250C.
Several positive colonies were analysed further. BglII, digestion confirmed the presence of a BglII site. In addition, single-stranded DNA was isolated from a BglII-site containing mutant (pT4-M) and subjected to dideoxy sequence analysis using a synthetic 17-mer primer, complementary to nucleotides 87-103 of the EFlaA gene Nagata, K. Nagashima, Y. Tsunetsugu-Yokota, K. Fuyimura, M. Miyaraki and Y. Kaziro I for extrachromosomal stable maintenance or integration, are 1 26 i* (1984) EMBO J. 3, 1825) (5'-CAATACCACCACACTTG-3'). The sequence obtained confirmed the successful introduction of the desired mutations.
c) The next step was to isolate the EFlaA promoter NH2-terminal maltase gene segment from pT4-M and to fuse it via BglII/BclI sticky end ligation to the rest of the maltase gene. This step restores the maltase coding region downstream of the EFlaA promoter and leader sequence (see Fig.
7c). Plasmid pGb-M6g was transformed to GM113, an E.
coli dam strain, in order to be able to use the Bcll site (which is methylation sensitive) (GM113: thr-, leuB6, proA2, tris-4, metBl, lacY1, galK2, ara-14, tsx33, thi-1, thyA12, i deoBl6, supE44, rpsL260, dam-3). A 3.8 kb BclI/HindIII fragment was isolated, containing the maltase gene except for the very NH 2 -terminal end. pT4-M was digested with BglII/HindIII and the large 4.1 kb fragment isolated (EFlaA promoter/NH 2 terminal and maltase gene). Both fragments S, were ligated to each other, resulting in pGb-EFMT-3. Sequence 20 analysis confirmed the correctness of all introduced mutations.
d) Finally, pGb-EFMT-3 was digested with EcoRV and HindIII to purify a 4.8 kbp. EFlaA/maltase promoter/gene fragment. From pGb-iA32/G418 (see Fig. an approximately 8.3 kb HindIII (partial)/EcoRV fragment was isolated. This consists of the pTZ19R backbone, the ADHI/maltose permease promoter/gene segment and the ADHI/G418res segment. Both were ligated to yield pGb-iRRol (see Fig. 7d).
7. pGb-RB2 This plasmid serves as cloning vehicle to integrate pieces of DNA into the SIT4 gene of Saccharomyces cerevisiae.
Its construction comprises the following steps (see Figures 8 and 9).
i :i 1 38 activity.
GD -13i, i 27 a. pTZ19R was digested with EcoRI and HindIII to replace its polylinker by a synthetically made DNA segment of nucleotides. This piece of DNA is made by annealing of the synthetic oligodeoxynucleotides 3 and 4 (see Fig. This short fragment contains EcoRI and hindIII sticky ends. Cloning of this DNA fragment into the pTZ19R vectcr does not restore the EcoRI and HindIII sites. The synthetic DNA fragment contains at the borders restriction sites for NotI and Sfil and in the middle an EcoRI site, as indicated. The resulting plasmid is designated pGb-SNENS.
0 0o b. An EcoRI fragment containing the SIT4 gene (Gottlin-Ninga and Kaback, vide supra) was isolated from pLF24 (also known having the code pLN420) and cloned into the EcoRI S 15 site of pGb-SNENS. This yielded pGb-Spons31. Due to lack of useful reference restriction sites, its orientation is unknown.
So° c. Plasmid pGb-Spons 31 contains a unique BglII 20 site in the middle of the SIT4 gene. This can be used as site into which any segment of DNA to be transferred to the SIT4 Sgene by gene replacement, can be cloned. To facilitate cloning manipulation, the SIT4 gene has been provided with a synthetic Spiece of DNA, containing several unique restricticn sites.
The construction of pGb-RB2 is outlined in Fig. 9.
The synthetic DNA fragment has two sticky BglII ends. Its orientation in pGb-RB2, as indicated in Fig. 9, is based on restriction enzyme analysis of pGb-RBN3 (see next.
j 1 30 8. pGb-RBN3 A 1.9 kb EcoRV/HincII fragment containing the G418res gene under control of the ADHI promoter (see also construction of pGb-iA32/G418), was cloned into the SmaT site of pGb-RB2. This yielded pGb-RBN3 (Fig. 1 28 9. pGb-RBRR1O This plasmid contains the maltose permease gene j under direction of the promoter alcohol dehydrogenase I and 5 the maltase gene under direction of the EFlaA promoter. Both Sare located on an 8.3 kb HindIII fragment which has been cloned into the SIT4 gene. Its construction is outlined in Fig. 11. To this end, pGb-iRROl was digested with HindIII and ligated onto pGb-RB2 x HindIII (treated with calf intestine phosphatase). This yielded pGb-RBRRO1.
pGb-RBREGO1 This plasmid contains the MAL-regulator gene under direction of the promoter alcohol dehydrogenase.
SI. pGb-RBREGO1 can be constructed as follows. From p21- 4 0 Needleman and C. Michels (1983), supra) the Sall fragment is isolated containing the regulatory protein gene.
This fragment is cloned into the Sall site of pTZ18R. This S 20 plasmid is commercially available (Pharmacia). Its orientation is such that the promoter area of the MAL-regulator gene is proximal to the T7-promoter sequence of pTZl8R. Using the sequence-primer of pTZ18R and other newly made oligonucleotide primers based on the DNA sequence obtained, the promoter area of the MAL-regulator gene and the NH2-terminal encoding part Sof the gene can be sequenced. This locates the position of the AUG-startcodon. When useful restriction sites are absent in Sthe promoter area, close to the AUG-startcodon, such a site (for instance BglII) can be introduced in that area via sitedirected mutagenesis with an oligonucleotide according to sstandard methods (see also construction of recombinant plasmids, section After such a mutagenesis the BglII-SalI fragment (containing the MAL-regulator gene without promoter area) and an EcoV-BanHI fragment (containing the ADHI promoter, see also Fig. 7d, pGb-iRR01) can be ligated together into pGb-RB2 (see L- 29 I C
SI
Fig. such that the MAL-regulator gene is under control of the ADHI promoter. This will yield plasmid pGb-iRBREG01.
Sequence analysis using the didec.ychaln methc°is 7!th oligonucleotides on ssDNA as template, can easily ccnfirm the correctness of the cloning steps and the crientation of the pronoter.
It will be appreciated to recogoirc that the abovementioned plasmids constructions merely serve as examples to illustrate the invention. Other promoters (preferably 3accharomyces) can be used (or other parts of the same promoter), other integration loci can be selected, other combinations of maltase, maltose permease and MAL-regulator (either under control of their own promoter or under control of another, preferably Saccharomyces promoter), can be mae, using one or more integration sites in the yeast genome. It will ultimately lead to the optimal ratio of maltase and maltose permease activity present during the entire period of anaerobic fermentation.
Yeast transformation Transformation of yeast strains was carried out (ccording to the method c f Ito et al. Ito, Y. Fukuda, K. Murata, A. Kimura (1963), J. Bacteriology 153, lh3--b3). it involves growing Saccharomyces in a standard yeast nutrient medium to a density of 1 to 25, desirably 4 to 10 0 1 olU rnn.
The yeast cells are then harvested, washed and pretreated with chaotropic ions particularly the alkali metal il.s, liiium, jU cesium or rubidium, particularly as the chloride or sulphate, more particularly the lithium salts, at concentrations about 2 mM to 1.0 M, preferably about 0.1 M. After incubating the cells for from about 5 to 120 minutes, preferably about minutes, with the chaotropic ion(s), the cells are then 3. Incubated with DNA for a short period of time at s<l 1-t temperature, generally from about 200C to 3500 for about minutes to 60 minutes. Desirably, polyethylene glycol is added at a concentration of about 25 to 50%, where the entire medium I may be diluted by adding an equal volume of a polyethylene glycol concentrate to result in the desired final I concentration. The polyethylene glycol will be of from about Ij 2000 to 8000 daltons, preferably about 4000 to 7000 daltons.
Incubation will generally be for a relatively short time, generally from about 5 to 60 minutes. Desirably, the incubation medium is subjected to a heat treatment of from about 1 to 10 minutes at about 3500 to 45°C, preferably about 42°C. For selection of transformants any useful marker may be used, such as phleomycin Genilloud, M.C. Garrido, F. Moreno (1984) Gene 32, 225), hygromycin B (Gritz et al.
(1983) Gene 25, 178) and aminoglycoside G418 (Jiminez et al.
(1980), Nature, 287, 869).
When yeast cells have been transformed with integrating plasmids, integration was directed to the MALlocus using BglII-digested DNA. The integrating plasmids used, contain two BglII sites, both in the maltase gene, 1.4 kb from each other. This generates double-stranded breaks, which are recombinogenic and stimulate interaction with homologous chromosomal DNA. The gap is repaired from chromosomal information during the integration event Orr-Weaver, J.W. Szostak, R. Rothstein (1981) Proc. Natl. Acad. Sci.
U.S.A. 78, 6354). The integration event yields one or a few copies of the plasmid vector Szostak, R. Cou (1979) Plasmid 2, 536). The exact copy number in these transformants, used in CO2-production experiments, has not been determined.
A scheme was developed in order to obtain stable yeast transformants which do not contain heterologous DNA.
Examples of heterologous DNA are the pTZ19R vector DNA and the -selection genes conferring resistance to the antibiotics G41b, phleomycin or hygromycin B. Briefly, the experimental set up was as follows (Figure 12) 1) One-step gene disruption of a SIT4 gene via transformation of yeast with pGb-RBN3 digested will Sfil.
Li I c ii control of ADHI promoter) conferring resistance to G418. EV, EcoRV; He, Hinc II.
*i! S- 31- Transformants have been selected for resistance to 0418. The outcome was strain ApGb-RBN3, in which a SIT4 gene has been i replaced by SIT4 gene, interrupted by the G418' gene under control of the ADHI promoter.
2) Strain ApGb-RBN3 was used as host strain in a cotransformation protocol with pUT332 and with pTh-R RR0l digested with Sfil. pUT332 is a 2p-derived episomal plasmid containing a gene confering resistance to phleomycin. The first selection in this cotransformation step was carrield out on plates containing phleomycin (30 pg/ml). In a certain percentage of these phleomycinr yeast cells (in the order of 0.1 to the interrupted SIT4 gene (with pADHI/G418r) S has been replaced by the cotransformed SIT4 fragment containing altered maltose permease and maltase genes. This second gene-replacement event resulted in a yeast which is again sensitive to G418. To select for yeast cells in which this second gene-replacement has taken place, phleomycinr transformants were replica-plated onto plates containing G418 (300 pg/ml). In cells which did not grow, the G418r gene embedded between SIT4 gene sequences, has been replaced by the altered MAL-genes, embedded between SIT4 gene sequences.
3) Phleomycinr G418sens tranformants were Sthen cured from the episomal plasmid pUT332 by growth on nonselective medium without phleomycin) during 10-20 generations. The resulting transformant ApGb-pRBRR01 is sensitive to both phleomycin and G418 and contains no u 30 procaryotic sequences. All the integration events have been verified at the DNA level with Southern blot experiments (data not shown).
The resulting strain can be used as host in subsequent transformations by use of another integration locus and/or in case of yeast strains which are diploid or polyploid at the other allele(s) of the SIT4 gene. Strain A is aneuploid and diploid for the chromosome containing the SIT4 gene. Both SIT4 genes of strain A were used as target I site for gene replacement. This ultimately yielded 1 transformant ApGb-p2RBRRO1#1. The use of both alleles for integration most likely also increased the genetic stability of the transformant, since the second integration event removed the polymorfism at that locus. Such polymorphic regions are sensitive to gene conversions which can result in the loss of the integrated sequences. The transformant obtained in this way has been analysed with Southern blot techniques and shows the hybridization pattern as predictea from the gene disruption events at both SIT4 genes.
The constructed vector pGb-RB2 which served as starting plasmid for pGb-RBN3 and pGb-RBRRO1, has several useful characteristics inspired by the following considerations: 1. Often a DNA segment has to be integrated, which S is constructed by fusing a yeast promoter to a (yeast) coding region of another gene. Gene replacements are of course only readily obtained if the transforming fragments possess on both sides sequences homologous to a target-sequence in the genome.
Therefore, a DNA segment has to be hooked onto the 3' end of the coding region (vide supra), which is derived from the same gene as the selected promoters. The disadvantage of this approach is that it requires many cloning manipulations, since not always the same promoter is used. In addition, often a i strong promoter is selected, derived from a gene, which is functional at the stages of interest (during vegetative growth, anaerobic fermentation etc.). After integration of the Sengineered fragment one copy of this gene is made nonfunctional.
Therefore, we wish to direct gene replacement at a locus, which is not expressed during vegetative growth. We have selected the SIT4 gene (sporulation-induced transcribed sequence), whose expression is well studied by Gottlin-Ninja I 1 I' a o 4 f4 i 4( r I I O I 33 and Kaback (supra), but of course other SIT genes or in general non-coding segments are appropriate. When the DNA construct of interest is cloned into this SIT4 gene, the two resulting halves of the SIT4 gene serve as homologous ends for recombination.
One could argue that the chromosomal area, in which the gene is located, is transcriptionally inactive during vegetative growth as a result of a silencer, analogous to the one described for the HMR-locus Brand et al. (1985) Cell 41, 41-48). This silencer DNA also represses transcription controlled by promoters, unrelated to mating-type promoters and can act on promoters 2600 bp away. Gottlin-Ninfa and Kaback (supra), however, have shown that the HIS3 gene is able to function during vegetative growth when integrated into the SIT4 gene.
2. To facilitate cloning manipulations, the SIT4 gene is provided with a synthetic piece of DNA, containing several unique restriction sites (polylinker with cloning sites). In addition, the polylinker contains at both sides stopcodons for translation in all possible reading frames (see Figure This is a safety-valve to stop translation of any possible hybrid transcript, which may be synthesized across the junction. Such a hybrid transcript may otherwise code for a protein, whose effect is unknown.
3. To achieve homologous recombination, the DNA segment to be integrated contains at both ends restriction sites for NotI and SfiI, which both recognize 8 bp sequences.
The frequency of occurrence of these restriction sites is very low and hence it is extremely unlikely, that a DNA segment to be cloned into the polylinker in the SIT4 gene, contains both recognition sites. Thus, once the DNA segment has been cloned into the SIT4 gene on plasmid pGb-RB2, restriction with NotI or SfiI liberates a DNA fragment, which can recombine by interacting with homologous sequences in the genome, i.e. at 34 the SIT4 locus. Although the very ends are part of the NotI or 1 Sfil site and hence not homologous, other studies have shown ;that apparently by limited exonuclease digestion in the cell i these sequences are removed H. Rudolph, J. Koenig- 1 Ranseo and A. Hinnen (1985) Gene 36, 87-95).
4. As starting plasmid the commercially available plasmid pTZ19r, a pUC19 derivative is used. This vector has the advantage that it has a high copy number and trat it possesses an origin of repliclation of the single-standed phage fl. This makes it very easy to isolate after infection with a helper phage single-standed DNA and to verify tie DNA sequences across the junctions with the aid of primers. This greatly facilitates the detailed description of manipulated S 15 DNA.
It will be appreciated that it is possible to apply Sthese improvements not only to bakers' yeast, but to other yeasts as well.
t4 0 cO2-production measurements a) in synthetic dough medium (Test A) Yeast cells were incubated in YEPMS medium (1% yeast extract; 2% bactopepton; 3.75% maltose; 1.25% sucrose supplemented with 200 ug/ml G418). Growth was at 3000 until late-log phase. Yeast cells were collected from 6 ml culture i and resuspended in 8.8 ml synthetic dough medium. Composition of this medium (per litre): saccharose 4.6 g; maltose 64.37 g; KHIbPO 2.07 g; Mg3S4.7H20 2.76 g; (NH4) 2 S04 0.67 g; casamine i acids 2.07 g; citric acid 4.02 g; Na 3 citrate 44.25 g; vitamin B1 9.2 mg; vitamin B6 9.2 mg; nicotinic acid 46 mg; pantothenate 18.2 mg; biotin 0.23 ug. During 10 minutes the suspension was allowed to equilibrate in a 280C waterbath, with moderate stirring after which the flasks containing the yeast suspension were connected via a tube to a "gasburette".
I.I
35 This burette was filled with a solution containing per liter i 20 ml indicator solution (1 g methylred; 0.5 g methylenblue; dissolved in 1 1 96% ethanol), 40 ml lN H 2
SO
4 and a trace of CuS04 (dissolved in HNO3). The displacement of the volume of this solution in the burette is a measure for the CO2production, which was measured during 165 minutes.
In each set of experiments values of CO2 production obtained have been corrected for environmental temperature and pressure to standard conditions of 28°C and 760 mm Hg, respectively. In addition, a correction was made for the amount of yeast. The colorimetric readings at bOO nm of the 'culture have been used as correction factor in order to equalize the amount of yeast per C02 measurement.
b) in dough (Test B and B') The CO2 gassing curves of compressed yeast grown t fed-batch wise on molasses was determined, in dough with no sugar added (lean dough) (Test B) or with 30% sugar (Test i*O The lean dough was prepared as follows: 1 g of compressed o 20 yeast (containing 28.5% dry matter), 34 ml salt solution A (1.25 g NaC1 dissolved in 34 ml of distilled water) and 62.5 g flour were mixed in a Hobart apparatus for 30 seconds at speed 1 and 2 minutes at speed 2 so as to obtain a well developed dough.
The 0J% sugar dough contained 2.0 g of compressed yeast (of 28.5% dry matter), 34 ml salt solution B (0.938 g NaC1 in 34 ml of distilled water), 62.5 g flour and 18.75 g sucrose 30% sugar with respect to flour). Mixing was as for lean dough.
The dough was then transferred to a round-bottom 711 flask. Gas-production measurement was started 7.5 minutes after mixing, by connecting the flasks containing the dough via a tube &o a gasburette (see section a) and performed during 165 minutes at 28°C. In the event that the dry matter content of the compressed yeast differs from the value indicated above, such yeast has been employed; however, the I, -j 36 measured value of the CO2 gassing power has then be corrected i2 ny multiplying the 002 gassing power by the ratio of the i required dry matter content to the actual measured value. In each set of experiments, values of C02 production obtained have been corrected for environmental tempeOrcure and pressure to 28 0 C and 760 mm Hg, respectively. In some cases additional calculations have been performed in which the gi val'e' obtained have been corrected for the percentage of N of the fed-batch grown yeast N is an indication of the protein content). Similar percentages of improvements were found E without this last correction.
c) in dough (Test C and C') The C02 gassing curves of dried yeast, such as instant dry yeast prepared according to procedures as described in US patent no. 3843800 and US 4341871 was determined in dough with no sugar added (test C) or with sugar (test These tests were performed in the same way as described in tests B and B' except that 300 mg of dried 20 yeast (containing 96% dry matter) and 600 mg of dried yeast (containing 96% dry matter) were used in tests C and C', respectively. Prior to the test the yeast was mixed with the flour and incubated for 11 minutes at 28"C.
Enzymatic analyses The capacity to transport maltose by yeast cells was determined using [U-14C]-maltose at a concentration of as a substrate at 300C. Details have been published by R.
Serrano (Supra). Maltase 3.2.1.20) was assayed for using p-nitrophenyl-a-D-glucopyranoside as a substrate in cell free extracts. The assay was carried out according to H. Halvorson and E.L. Elias, Biochim. Biophys. Acta (1958) 30, 28.
37 Substrate consumption and product formation in liquid medium The disappearance of maltose and glucose from liquid media was quantitated using standard HPLC-techniques.
One litre of medium contained: 100 g maltose, 10 g glucose, g (NHi)2S04, 4.0 g MgSO4.7H20, 4 g KH2PO4, 4 g casamino acids (Difco), 4 g citric acid.H20, 45 g trisodiumcitrate.2H 2 0, 10 mg vitamin Bl, 10 mg vitamin B6, mg nicotinic acid, 20 mg Ca-D(+)-pantothenate and 0.02 mg biotin. The pH was adjusted to 5.7. Two ml of medium was added to a suspension of yeast (20 mg dry weight/2.0 ml of distilled water). This mixture, termed medium A, was incubated at 28 0
C.
Medium B was like medium A but contained 20 times more glucose. The experiment was carried out under anaerobic conditions.
Protein determination Protein of cell-free extracts and of whole cells 20 was determined by the microbiuret method of J. Goa, Scand. J.
Chim. Lab. Invest. (1953) 5, 218. Ovalbumin served as a standard.
Keeping quality Qompressed yeast was stored in closed plastic containers at 23 0 C during 4 days. Keeping quality is defined as the percentage of remaining gassing power after this period.
Manufacture of compressed yeast A culture of a yeast strain was grown in a series of fermentors. Cells were cultivated in 10 litre laboratory fermentors with a net volume of 6 litres. During the fermentation pH and temperature were maintained at desired cj 1 38 values by automatic control. The fermentation rtcipe used is based on procedures described by G. Butseheck L&nd R.
Kautzmann, Die Hefen, Band II Technologie der Hefen P. 501-591 (1962), Verlag Hans Carl, Ntrnberg, FRG and those published oy G. Reed and H.J. Peppler in Yeast Technology, the AVI Publishing Company Inc., Westport, Connecticut, USA (1973).
The cultivation conditions of the final fermentation were irn particular: molasses applied consisted of 80% by weight of bept molasses and 20% by weight of cane molasses, calculated on the basis of 50% sugar the required amount of phosphate was added in tne form of mono-ammonium phosphate, prior to inoculation.
the temperature increased from 2b°C to during the fermentation according to Table 1 nitrogen was supplied during the fermcntation u6 a 10% solution of NH 3 in water according to Table 1.
pH was kept at 5.0 during the first 8 hours of the fermentation and increased thereafter according to Table i to 6.2 at the end of the fermentation.
Per kg of molasses containing 50% fermentable sugars 12 mg of vitamin Bl was added prior to inoculation.
The yeast obtained by this fermentatlon was concentrated and washed with tap water in a laboratory m"u centrifuge. Yeast creams were compressed to a dry matter content varying between 26 and 32%.
The obtained protein content x 6.25) varied between 42-55% of dry weight as a consequence of aifferent quantities of ammonia applied during the fermentation.
T
4 ;a 'i Table 1 39 Fermentation recipe used for the baker's yeast fed-batch wise production of Hours after Molasses supply pH T Ammonia supply inoculation of total of total amount added) amount added) 0 0- 1 1- 2 2- 3 3- 4 4- 5 6 b- 7 7- 8 8- 9 9-10 10-11 11-12 5 5 5 5 5 5 5 5 5 5.3 5.6 5.9 6.2 28.0 28.0 28.0 28.5 28.5 29.0 30.0 30.0 30.0 30.0 30.0 30.0 30.0 YnS -40 Example 1 C0 2 -production of yeast transformed with 24-derived plasmids containing genes derived from the MAL6 locus Commercial baker's yeast strains A and C have been transformed with pGb-eMAL6g (maltose permease and maltase, see Fig. pGb-eMAL61 (maltose permease, see Fig. 2) and pGbeHAL63 (MAL-regulator, see Fig. The MAL genes still contain their original promoters. The nomenclature of the transformed yeast strains is as follows: ApeG418 denotes strain A transformed with peG418. Other transformed strains J have been indicated in an analogous way. The effects of these plasmids on the C0 2 -production in synthetic dough medium is summarized in Table 2. The host strain, transformed with starting peG418 (see Fig. 1) serves as a reference, since we have found that the mere presence of a multicopy plasmid has a negative effect on the gas production.
All transformants display major C02 production improvements, relative to the control. The combination of extra copies of both maltose permease and maltase genes gives the highest enhancement, about 40% in strain A and 18% in strain C.
Transformants ApGb-eMAL6g and CpGb-eMAL6g have also been tested in dough with no added sugar. In this case the yeast was grown fed-batch wise on molasses.
Again, major improvements in C02 production were obtained (Table 3).
I 112 y I 41 Table 2 Gas production of strain A and strain C transformed with 2tderived MAL plasmids, relative to the vector-transformed strains. 002 production was measured in synthetic dough medium (see experimental procedures) and corrected to 285 mg dry matter. Data are mean values of several experiments.
4 4 strains ApeG418 ApGb-eMAL6g ApGb-eMAL61 ApGb-eMAL63 CpeG418 CpGb-eMAL6g CpGb-eMAL61 100 minutes 165 minutes 100 157 144 119 100 121 117 100 141 123 115 100 lib 114 4 O Table 3 Relative gas production in dough of strains A and C, transformed with 2i-derived plasmids peG418 and pGb-eMAL6g, 002 production was corrected to 285 mg dry matter.
strains 60 minutes 100 125 100 minutes 100 125 120 minutes 100 125 165 minutes 100 121 ApeG418 ApGb-eMAL6g CpeGI418 CpGb-eMAL6g 100 151 100 141 100 138 100 129 I 1.
ccL~~;uurp ,s i 42 Example 2 002 production of yeast strains transformed with integrating plasmids containing recombinant maltase and/or maltose permease genes Parental yeast strain A has been transfo'med with pGb-iA32/G41b (main feature: ADHl/maltose permease; see Figure 6) and pGb-iRRol (main feature: ADHl/maltose permease and 10 EFlaA/maltase; see Figure 7).
Parental strain A and both integrative transformants are grown fed-batch wise on molasses similar to the commercial aerobic fermentation (see Table After harvesting the S cells, C02 production is measured in a standard dough tet with no sugar added. The gas production, as analysed in chis test, is summarized in Table 4. Integration of pGb-iA32/G418 into the chromosome of strain A improves gas production in dough significantly. The relative improvement varies somewhat S depending on time of measurement (see Table When in addition to an altered maltose permease gene an altered maltase gene is integrated in the chromosome of commercial strain A using pGb-iRHol gassing power is even further improved. In this typical experiment about 30% more 002 i produced after 165 minutes in a lean dough, which corresponds to a level of about 410 ml C02 285 mg dry weight of yeast.
In a 30% dosage sugar dough no substantially differences in C02 production of the transformants were noticed compared to the parental strain (about 190 ml mg dry weight of yeast).
30 The obtained improvement in leavening activity is maintained during storage at 23°0. The loss of leavening activity during storage is virtually identical for parental strain A and the novel strains (see Table :b; 43 Table 4 Relative gas production of strain A and its rDNA derivatives provided with altered maltase and/or maltose permease genes.
Gas values have been corrected to 285 mg dry matter. No sugar was added to tne dough.
Strain 60 100 120 165 .0 minutes minutes minutes minutes A 100 100 100 100 ApGb-iA32/G418 113 115 115 111 ApGb-iRRol 131 136 138 133 c; I I 4 Table SI Keeping quality of strain A and its rDNA derivatives provided S 20 with altered maltase and/or maltose permease genes. Leavening activity was measured as in Table 4 after keeping of compressed yeast at 23°C for 4 days.
Strain keeping quality of original leavening activity) A 90 ApGb-iA32/G48 91 ApGb-iRRol 88
I
i 44 Example j C02 production of a yeast strain wnich contain3 recombinant maltase and maltose permease genes and no heterologous DNA.
Parental strain A has been genetically modified such that a pADHI/maltose permease gene and a pES±lA/A'mal'tawe gene were introduced into the SIT4 gene on both homologous chromosomes. This strain, abbreviated ApGb-p2RBRR01 1, has been constructed using the methods and plasmids as desc,-ibed previously (see sections of transformation and construction of plasmid of pGb-RBN3 (Fig 10) and pGb-RBRR01 (Fig. 11) and the general scheme of transformation via gene-replacement.
S Parental strain A and the homologous transformant ApGbp2RBRR01 1 have been grown fed-batch wide on molasses similar to the commercial aerobc fermentation (see Table 1).
After harvesting the cells, 002 production is measured in a standard dough test with no sugar added.
Table 6 summarizes the results. In the "lean" dough the improvement is about lb% after 165 minutes, which corresponds to a level of about 367 ml C02/285 mg dry weight of yeast. This strain contains two copies each of a maltose permease gene under contr l of the ADHI promoter and a imaltase gene under control of the EFlaA promoter. In Table 4 i;s 3hownr that strain ApGb-iRRO1 has an improvement of about 30%. An initial estimation of the number of pGb-iRRO1 molecules Sintegrated into a MAL-locus of strain A, gives a copy number of integrated plasmid molecules of at least 3. By further increasing the copy number of altered maltose permease and maltase genes in strain ApGb-p2RBRR01l 1 by integration in other sporulation-specific genes) a homologous transformed yeast strain can be obtained with at least similar gas production levels as strain ApGb-iRRO1.
1 L~c. ~e i 45 Table 6 Relative gas production of strain A and its homologous rDNA derivative provided with altered maltase and maltose permease genes. Gas values have been corrected to 285 mg dry matter. No sugar was added to the dough.
Strain 60 100 120 165 minutes minutes minutes minutes A 100 100 100 100 ApGb-p2RBRR01#1 124 128 127 118 t o
*J
i ~R _i _i i~-nur 46 Example 4 Enzyme activities and substrate uptake rates of yeast strains transformed with integrating plasmids containing recombinant maltase and/or maltose permease genes.
As described above, the expression of maltose permease and maltase is subject to maltose induction and glucose repression. This phenomenon is shown in Fig. 13 for wild-type cells of strain A. Specific activities of maltose permease and maltase do not increase until most of the glucose has been utilized.
The activity of maltose permease at the onset of dough-rise is increased by introduction of an altered maltose permease gene into the yeast genome (strain ApGb-iA32/G4i8) shown in Fig. 14.
Surprisingly, activities of maltase were increased as well in this construct (Fig. 15). This novel strain Ap3b- LA32/G418 fermented maltose more rapidly than the parental strain A in medium A which contains maltose as main carbon and energy source (Fig. 16). In medium B containing glucose as main carbon and energy source this effect was less pronouri.c' (Fig. 17).
In addition to an altered maltose permease gene an altered maltase gene was integrated in the chromosome yieldin strain ApGb-iRRol. This strain fermented maltose at an -ven higher rate in medium A (Fig. 16) and also in medium B (Fig. 17). Despite the high extra extracellular concentration i 30 of glucose considerable amounts of maltose were metabolized by this novel strain. Strain ApGb-iRRol exhibited higher specific activities of maltase and maltose permease during dough-rise than parental strain A and strain ApGb-iA32/G418 (Fig. 14 and

Claims (32)

1. A transformed baker's yeast providing for an enhanced rate of sugar fermentation as compared to the untransformed parent baker's yeast, said transformed baker's yeast comprising: at least one, preferably homologous, DNA construct present in said yeast as a result of transformation, said DNA construct comprising at least one gene expressed in said yeast encoding maltose permease, maltase or a maltose regulatory protein, promoting the maltose permease activity and/or the maltase activity irrespective of the presence of other sugars than maltose the gene being capable of expression in said yeast.
2. A baker's yeast according to claim 1 wherein said construct comprises at least two of said genes.
3. A baker's yeast according to claim 2 wherein said genes or combinations thereof have been brought under transcriptional control which is not sensitive to glucose repression and is not subject to maltose induction.
4. A baker's yeast according to any one of the o preceding claims wherein said gene is under transcriptional control of alcohol dehydrogenase I (ADHI) and/or translation elongation factor (EFlA) promoter. A baker's yeast according to claim 4 wherein said promoters are derived from a yeast belonging to the genus Saccharomyces, preferably Saccharomyces cerevisiae.
6. A baker's yeast according to any one of the preceeding claims wherein said construct is a portion of an episomal element.
7. A baker's yeast according to any one of the preceding claims wherein said construct is integrated into a chromosome of said yeast.
8. A baker's yeast according to any one of the preceding claims, which comprises at least two of said constructs.
9. A baker's yeast according to any one of the preceding claims wherein said yeast is free of heterologous DNA. A transformed baker's yeast capable of improving the 7 -_ermentation rate of maltose into ethanol and carbon dioxide 0 /1943U -I -48- comprising a DNA construct substantially fee of prokaryotic DNA, said DNA construct comprising at least one gene expressed in said yeast encoding maltose permease, maltase or a maltose regulatory protein, promoting the maltose permease activity and/or the maltase activity irrespective of the presence of other sugars than maltose the gene being capable of expression in said yeast.
11. A baker's yeast according to claim 10 wherein maltase is brought under transcriptional gene expression control of a translation elongation factor (EFloA) promoter.
12. A baker's yeast according to claim 10 or 11 wherein maltose permease is brought under transcriptional gene expression control of an alcohol dehydrogenase I (AKHI) promoter.
13. A baker's yeast according to any one of claims 10 to 12 wherein said promoters are derived from a yeast belonging to the genus Saccharomyces.
14. A baker's yeast having a moisture content of 3 to 8% which is produced by drying a yeast obtained according to any one of claims 1 to 13. 'o 15. A baker's yeast according to claim 14 wherein said yeast is belonging to the genus Saccharomyces, preferably said yeast is Saccharomyces cerevisiae.
16. A baker's yeast obtained by strain improvement procedures other than DNA mediated transformation using a yeast according to any one of claims 1 to
17. A baker's yeast selected from the group consisting of: Saccharomyces cerevisiae strain ApGb-iA32/G418, Saccharomyces cerevisiae strain ApGb-iRRol Saccharomyces cerevisiae strain ApGb-eMAL6g, Saccharomvues cerevisiae strain ApGb-eMAL61, Saccharomyces cerevisiae strain ApGb-eMAL63, Saccharomvces cerevisiae strain CpGb-eMAL6g and Saccharomyces cerevisiae strain ApGb-eMAL61. Saccharomyces cerevisiae strain ApGb-p2RBRR01#1
18. A compressed, instant dry or active dry baker's rTyeast obtained from a yeast according to any one of claims 1 S 17. fM PqW/1943U j_ Ir 1 -49- i 19. A compressed baker's yeast, obtained from a yeast according to any one of claims 1 to 13, which shows a gas production of at least 340 ml/285 mg dry weight of yeast in 165 minutes in Test B and a gas production of at least 170 ml/285 mg dry weight of yeast in 165 minutes in Test B', preferably shows a gas production of 380-450 ml/285 mg dry weight of yeast in Test B in 165 minutes and a gas production of 240 ml/285 mg dry weight of yeast in 165 minutes in Test more preferably shows a gas production of at least 400 ml/285 mg dry weight of yeast in 165 minutes in Test B and a gas production of at least 190 ml/285 mg dry weight of yeast in 165 minutes in Test B' A compressed baker's yeast, obtained from a transformed yeast according to any one of claims 1 to 13 which shows a gas production of 400-500 ml/285 mg dry weight of yeast in 165 minutes in Test B, preferably shows a gas production of 440 ml/285 mg dry weight of yeast in 165 minutes in Test B.
21. An instant dry or an active dry baker's yeast obtained by drying the compressed yeast according to claim 19 S or
22. A dried baker's yeast, obtained from a transformed yeast according to any one of claims 1 to 13 which shows a gas production of 310-360 ml/285 mg dry weight of yeast in I 165 minutes in Test C and a gas production of 145-195 ml/285 mg dry weight of yeast in 165 minutes in Test C', respectively, preferably shows a gas production of at least 330 ml/285 mg dry weight of yeast in 165 minutes in Test C and a gas production of at least 155 ml/285 mg dry weight of yeast in 165 minutes in Test or which shows a gas production of 320-400 ml/285 mg dry weight of yeast in 165 minutes in Test C, preferably shows a gas production of at least 350 ml/285 mg dry weight of yeast in 165 minutes in Test C.
23. A vector selected from the group consisting of: pGb-eMAL6g pGb-eMAL61, pGb-eMAL63, pGb-iA32/G418, S '..,pGb-iRRol and S..MW/1943U .1 A pGb-M6g(A-9). pGb-RBRRO1 pGb-RBN3 pGb-RBREGO1.
24. A dough or similar products which comprises a yeast according to any one of claims 1 to 22. A process to produce leavened flour products, or alcoholic beverages and other alcoholic products which comprises the use of a yeast according to any one of claims 1 to 22.
26. A process to produce a transformed baker's yeast capable of improving the fermentation rate of sugars which comprises the introduction into a yeast of at least one homologous DNA construct which comprises at least one gene expressed in said yeast encoding maltose permease, maltase or a maltose regulatory protein, promoting the maltose permease activity and/or the maltase activity irrespective of the presence of other sugars than maltose the gene being capable of expression in said yeast. "0 27. A process according to claim 26 wherein said construct comprises at least two of said genes.
28. A process according to claim 27 wherein said gene is under transcriptional control of alcohol dehydrogenase I (ADHI) and/or translation elongation factor (EFloA) promoters, respectively.
29. A process according to any one of claims 26 to 28 wherein said gene or combinations thereof have been brought under transcriptional control which is not sensitive to glucose repression and/or is not subject to maltose induction. A process according to any one of claims 26 to 29 wherein said construct is a portion of an episomal element.
31. A process according to any one of claims 26 to 29 wherein said construct is integrated into a chromosome of said yeast.
32. A process according to any one of claims 27 to 31 which comprises the introduction of at least two of said DNA constructs.
33. A process according to any one of claims 26 to 29 or 1 to 32, wherein said yeast is free of heterologous DNA T D /1943U i. _I -51- which comprises the integration of genes into the chromosome using gene replacement techniques.
34. A process according to claim 33 wherein a chromosomal sporulation-specific gene is replaced by a DNA segment comprising the same identical sporulation-specific gene into which genes described in claim 26 or 31 have been inserted. A process according to claim 28 wherein said promoters are derived from a yeast belonging to the genus Saccharomyces.
36. A process according to any of claims 26 to wherein said yeast belongs to the genus Saccharomyces, preferably Saccharomyces cerevisiae.
37. A process to produce a dough or similar products which comprises the application of yeast produced according to any one of claims 26 to 36.
38. A process to produce alcoholic beverages and other alcoholic products which comprises the use of yeast produced according to any one of claims 26 to 36.
39. A process to produce bread and related products which comprises the use of yeast produced according to any one of claims 26 to 36. A process to produce an enzyme with maltase or maltose permease activity which comprises the use of yeast produced according to any one of claims 26 to 36.
41. A yeast, as claimed in claim 1, substantially as hereinbefore described with reference to any one of the examples.
42. A process, as claimed in claim 25, substantially as hereinbefore described with reference to any one of the examples. DATED: 19 November 1990 PHILLIPS ORMONDE FITZPATRICK Patent Attorneys for: GIST-BROCADES N.V. i
AU21868/88A 1987-09-03 1988-09-05 New yeast strains providing for an enhanced rate of the fermentation of sugars, a process to obtain such yeasts and the use of these yeasts Ceased AU606989B2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP87201670 1987-09-03
EP87201670 1987-09-03
EP88200453 1988-03-09
EP88200453 1988-03-09

Publications (2)

Publication Number Publication Date
AU2186888A AU2186888A (en) 1989-03-09
AU606989B2 true AU606989B2 (en) 1991-02-21

Family

ID=26109303

Family Applications (1)

Application Number Title Priority Date Filing Date
AU21868/88A Ceased AU606989B2 (en) 1987-09-03 1988-09-05 New yeast strains providing for an enhanced rate of the fermentation of sugars, a process to obtain such yeasts and the use of these yeasts

Country Status (16)

Country Link
JP (1) JP2683253B2 (en)
KR (1) KR890005265A (en)
AT (1) ATE140970T1 (en)
AU (1) AU606989B2 (en)
CA (1) CA1335264C (en)
DE (1) DE3855453T2 (en)
DK (1) DK490588A (en)
ES (1) ES2092467T3 (en)
FI (1) FI100473B (en)
GR (1) GR3021138T3 (en)
IE (1) IE76719B1 (en)
IL (1) IL87661A (en)
NO (1) NO174214C (en)
NZ (1) NZ226020A (en)
OA (1) OA08910A (en)
PT (1) PT88394B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4430133B1 (en) * 2008-09-09 2010-03-10 サントリーホールディングス株式会社 Glucose-induced inactivation / degradation resistance transporter gene and use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL75210A0 (en) * 1984-05-22 1985-09-29 Bioteknika International Yeast vector
NZ216353A (en) * 1985-06-05 1988-05-30 Univ Kentucky Res Found Manufacture of lac + fungi
GB2178431B (en) * 1985-07-15 1989-11-22 Bioteknika International Genetically engineered yeast strains

Also Published As

Publication number Publication date
NO883919L (en) 1989-03-06
ES2092467T3 (en) 1996-12-01
PT88394B (en) 1992-10-30
PT88394A (en) 1989-07-31
NZ226020A (en) 1991-02-26
AU2186888A (en) 1989-03-09
JP2683253B2 (en) 1997-11-26
NO883919D0 (en) 1988-09-02
IL87661A (en) 1993-03-15
DE3855453T2 (en) 1997-01-09
ATE140970T1 (en) 1996-08-15
JPH01153082A (en) 1989-06-15
IE882660L (en) 1989-03-03
KR890005265A (en) 1989-05-13
CA1335264C (en) 1995-04-18
IL87661A0 (en) 1989-02-28
FI884064A0 (en) 1988-09-02
NO174214C (en) 1994-03-30
FI100473B (en) 1997-12-15
DE3855453D1 (en) 1996-09-05
IE76719B1 (en) 1997-11-05
OA08910A (en) 1989-10-31
DK490588A (en) 1989-03-04
DK490588D0 (en) 1988-09-02
FI884064A (en) 1989-03-04
NO174214B (en) 1993-12-20
GR3021138T3 (en) 1996-12-31

Similar Documents

Publication Publication Date Title
FI114481B (en) Selection marker gene-free filamentous fungal strains, process for their preparation, and use of these strains
USRE37767E1 (en) Highly stable recombinant yeasts for the production of recombinant proteins
EP0450430B1 (en) DNA sequence comprising a structural gene coding for xylose reductase or xylose reductase and xylitol dehydrogenase
Rubio‐Texeira et al. Highly efficient assimilation of lactose by a metabolically engineered strain of Saccharomyces cerevisiae
US5858764A (en) Yeast strains for saccharide fermentation
AU604484B2 (en) Induction of galactose regulated gene expression in yeast
EP0245481B1 (en) Yeast strains
CN109136254B (en) Efficient saccharomyces cerevisiae traceless gene knockout method and application thereof
US6107093A (en) Recombinant cells that highly express chromosomally-integrated heterologous genes
EP0306107B1 (en) New yeast strains providing for an enhanced rate of the fermentation of sugars, a process to obtain such yeasts and the use of these yeats
US20070172937A1 (en) Recombinant cells that highly express chromosomally-integrated heterologous genes
Nakazawa et al. Partial restoration of sporulation defect in sake yeasts, Kyokai no. 7 and no. 9, by increased dosage of the IME1 gene
EP0560885B1 (en) Recombinant cells that highly express chromosomally-integrated heterologous genes
EP0147198B1 (en) Fermentation processes and their products
CA2379034A1 (en) Metabolically engineered microbial cell comprising a modified redox activity
AU606989B2 (en) New yeast strains providing for an enhanced rate of the fermentation of sugars, a process to obtain such yeasts and the use of these yeasts
Jearnpipatkul et al. Factors encoded by and affecting the holding stability of yeast plasmid pSR1
Ohkuma et al. Identification of a centromeric activity in the autonomously replicating TRA region allows improvement of the host-vector system for Candida maltosa
JP4580055B2 (en) A baker&#39;s yeast with high amino acid accumulation
JP3949734B2 (en) Protease inhibitor production method
US5268285A (en) Strains of yeast with increased rates of glycolysis
Kim et al. The construction of a stable starch-fermenting yeast strain using genetic engineering and rare-mating
Hsieh et al. An autoselection system in recombinant Kluyveromyces lactis enhances cloned gene stability and provides freedom in medium selection
Wolf et al. Schwanniomyces occidentalis
JPS61502939A (en) Method for producing strains, especially yeast, transformed by expression vectors, which can be cultured in complete medium without selective pressure, and the strains thus obtained

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired